Invitation to Idorsia's full year financial results 2022

Invitation to Idorsia's full year financial results 2022

Idorsia will publish its full year financial results 2022 on Tuesday February 7, 2023, at 07:00 CET An investor conference call and webcast will be......

Idorsia submits European marketing authorisation

Idorsia submits European marketing authorisation

The application includes data from the Phase 3 registration study of patients with resistant hypertension, where aprocitentan demonstrated a sustained......

menu
menu